GAMMA Investing’s TG Therapeutics TGTX Stock Holding History

GAMMA Investing’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$282K	Buy	5,140 +1,216	+31%	+$49.8K	0.01%	1018
2026 Q1	$130K	Buy	3,924 +426	+12%	+$12.7K	0.01%	1452
2025 Q4	$104K	Sell	3,498 -131	-4%	-$4.28K	0.01%	1547
2025 Q3	$131K	Sell	3,629 -856	-19%	-$28.2K	0.01%	1277
2025 Q2	$161K	Sell	4,485 -58	-1%	-$2.16K	0.01%	1060
2025 Q1	$179K	Buy	4,543 +1,986	+78%	+$66.8K	0.01%	820
2024 Q4	$77K	Buy	2,557 +2,171	+562%	+$62.3K	0.01%	1308
2024 Q3	$9.03K	Buy	386 +327	+554%	+$7.14K	﹤0.01%	2503
2024 Q2	$1.05K	Buy	59 +9	+18%	+$144	﹤0.01%	3046
2024 Q1	$761	Hold	50	–	–	﹤0.01%	3002
2023 Q4	$812	Buy	+50	New	+$581	﹤0.01%	2849

Other funds holding TGTX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

GAMMA Investing's TGTX Position: Q2 2026 in Review

GAMMA Investing increased its TG Therapeutics (TGTX) stake by 31% in Q2 2026, buying an estimated $49.8K and bringing the position to 5,140 shares worth $282K. The position accounts for 0.01% of the portfolio, ranked #1018.

GAMMA Investing first reported a position in TGTX in Q4 2023 and has held it in 11 quarters since. 78 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

GAMMA Investing held 5,140 shares of TG Therapeutics worth $282K as of Q2 2026.
GAMMA Investing bought 1,216 TG Therapeutics shares in Q2 2026, an estimated $49.8K.
TG Therapeutics made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1018 holding.
GAMMA Investing first reported a position in TG Therapeutics in Q4 2023 and has held it in 11 quarters since.
78 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.